One of the great parts about the Cymerus manufacturing process is it doesn’t rely on fetal bovine serum as an MSC expansion culture medium (or xenongen or murine feeder).
This eliminates any adverse reaction caused by, for instance, injecting trace cow proteins into the blood stream. This is why MSB product has a large disclaimer on adverse reactions (turns out most ppl’s immune systems reject foreign protein compounds)
- Forums
- ASX - By Stock
- Ann: CYP-001s FDA Approval Pathway Not Impeded
CYP
cynata therapeutics limited
Add to My Watchlist
5.56%
!
17.0¢

One of the great parts about the Cymerus manufacturing process...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
17.0¢ |
Change
-0.010(5.56%) |
Mkt cap ! $38.41M |
Open | High | Low | Value | Volume |
17.0¢ | 17.0¢ | 16.5¢ | $21.40K | 127.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 425750 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 90178 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 415749 | 0.165 |
7 | 617558 | 0.160 |
2 | 16451 | 0.155 |
3 | 120000 | 0.150 |
2 | 85000 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 90178 | 3 |
0.185 | 38745 | 2 |
0.190 | 189688 | 3 |
0.195 | 19300 | 1 |
0.200 | 108000 | 4 |
Last trade - 14.06pm 13/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |